© 2025 TPM MEDIA LLC. ALL RIGHTS RESERVED.
FILE - This April 12, 2011 electron microscope image made available by the National Institute of Allergy and Infectious Diseases shows an H9 T cell, blue, infected with the human immunodeficiency virus (HIV), yellow.... FILE - This April 12, 2011 electron microscope image made available by the National Institute of Allergy and Infectious Diseases shows an H9 T cell, blue, infected with the human immunodeficiency virus (HIV), yellow. Research suggests that a shot every one to three months may someday give an alternative to the daily pills that some people take now to cut their risk of getting HIV from sex with an infected partner. An experimental drug given in periodic shots completely protected monkeys from infection in two studies reported at an AIDS conference on Tuesday, March 4, 2014. (AP Photo/NIAID) MORE LESS

Here is a brief follow-up on the question TPM Reader MA addresses in an earlier post: why does the Trump administration have it in for biomedical/disease research? It’s a really good question and one I have not seen an adequate explanation for. But having been reporting on this for a few months now I think I do get the outlines of it.

Want to keep reading?

Join and get The Backchannel member newsletter along with unlimited access to all TPM articles and member features.

JOIN TPM
Josh Marshall is the founder and Editor-in-Chief of TPM.
Latest In The Backchannel
More From The Ed Blog